Iasis Molecular Sciences INC.
Spokane, WA · Medtech · Private
Antimicrobial composite paints and epoxy flooring incorporating novel copper-based ion exchange biocides for hospital surfaces
- Grants
- $2.2M
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 0 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · FAST? Complementary Disinfection for the Healthcare Environment | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · FAST? Complementary Disinfection for the Healthcare Environment | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of SupraGuard ETT, A Next Generation Composite Endotracheal Tube for the Prevention of Ventilator-Associated Pneumonia | $225,135 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of SupraGuard ETT, A Next Generation Composite Endotracheal Tube for the Prevention of Ventilator-Associated Pneumonia | $225,135 | |
| Federal grant | Department of Health and Human Services · Phase II · Clinical Ecosystem Surfaces for Improved Disinfection Outcomes and the Prevention of HAI Transmission | $686,990 | |
| Federal grant | Department of Health and Human Services · Phase II · Clinical Ecosystem Surfaces for Improved Disinfection Outcomes and the Prevention of HAI Transmission | $578,861 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2138 | WI-SENSE LLC | — | — |
| 2139 | IMMUNICOM, INC. | — | — |
| 2140 | Embark Medical | — | — |
| 2141 | Iasis Molecular Sciences INC. | — | — |
| 2142 | VESAREX LLC | — | — |
| 2143 | ADAPT DESIGN WORKS, LLC | — | — |
| 2144 | MS2 Array, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Antimicrobial And Biologically Active Polymer Composites And Related Methods, Materials, Coatings And Devicesapplication
- Antimicrobial And Biological Active Polymer Composites And Related Methods, Materials And Devicesapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.